Department of Cardiology, Dr Ram Manohar Lohia Hospital & PGIMER, New Delhi, 110001, India.
Indian Heart J. 2020 Nov-Dec;72(6):508-516. doi: 10.1016/j.ihj.2020.11.009. Epub 2020 Nov 19.
Large intracoronary thrombus has been reported in significant number of patients with STEMI. Primary PCI is the current standard of care in patients of STEMI. Despite the availability of dual antiplatelets, GP IIb/IIIa inhibitor and effective anticoagulation regimens, large intracoronary thrombus remains one of the biggest challenge to interventional cardiologists during primary PCI. Large intracoronary thrombus may lead to distal embolization, no/slow reflow or embolization into a non-culprit vessel and is associated with adverse cardiovascular outcome. There is no ideal management strategy. We hereby discuss the current available methods/strategies to deal with large thrombus burden encountered during primary PCI, in the current manuscript.
急性 ST 段抬高型心肌梗死(STEMI)患者中存在大量冠状动脉内血栓。在 STEMI 患者中,经皮冠状动脉介入治疗(PCI)是目前的标准治疗方法。尽管有双联抗血小板、血小板糖蛋白Ⅱb/Ⅲa 抑制剂和有效的抗凝方案,但大冠状动脉内血栓仍然是 PCI 期间介入心脏病学家面临的最大挑战之一。大冠状动脉内血栓可能导致远端栓塞、无复流或慢复流或栓塞到非罪犯血管,与不良心血管结局相关。目前尚无理想的管理策略。在本文中,我们讨论了目前在 PCI 中处理大量血栓负荷的可用方法/策略。